- What is the current status of Regenera Pharma?
- Regenera Pharma is currently inactive, having ceased operations in November 2020.
- What was Regenera Pharma's primary focus?
- Regenera Pharma was a clinical-stage pharmaceutical company focused on developing innovative drugs for the treatment of optic nerve neuropathies, specifically ischemic optic neuropathy.
- What was the total amount of funding raised by Regenera Pharma?
- Regenera Pharma raised a total of $24,025,000 across multiple funding rounds.
- When was Regenera Pharma founded?
- Regenera Pharma was founded in June 2008.
- What was the most recent funding round for Regenera Pharma?
- The most recent funding round for Regenera Pharma occurred in January 2018, with aMoon Fund participating.
- What was Regenera Pharma's employee count?
- Regenera Pharma had 1-10 employees.
- What clinical studies was Regenera Pharma planning or conducting?
- Regenera Pharma was planning a Phase 3 study in the U.S. for RPh201 in NAION patients and a Phase 2 study in Canada for RPh201 in individuals with Alzheimer's disease.
- With which institution did Regenera Pharma collaborate on stroke recovery research?
- Regenera Pharma collaborated with the Henry Ford Health System to investigate RPh201's effects on stroke recovery in a rat model.